Atai Life Stock Executives

ATAI
 Stock
  

USD 3.01  0.08  2.59%   

Atai Life employes about 87 people. The company is managed by 13 executives with total tenure of roughly 111 years, averaging almost 8.0 years of service per executive having 6.69 employees per reported executive. Examination of Atai Life management performance can provide insight into the company performance. Note, employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with Atai Life Sciences future performance.
Please continue to Trending Equities.
  
  ChengYaw Sun  CEO
CEO, Director
  Xiaofeng Ma  Chairman
Co-Founder, Chairman, CEO and Chairman of Nominations Committee
  Jack Huang  President
President Director

Atai Life Management Team Effectiveness

Atai Life Sciences has return on total asset (ROA) of (20.53) % which means that it has lost $20.53 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (49.68) %, meaning that it created substantial loss on money invested by shareholders. Atai Life management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.

Atai Life Workforce Comparison

Atai Life Sciences is number one stock in number of employees category among related companies. The total workforce of Biotechnology industry is presently estimated at about 124,889. Atai Life adds roughly 87.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.

Atai Life Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Atai Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Atai Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Atai Life insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Bardin Stephen over three months ago via Macroaxis 
Atai Life exotic insider transaction detected
Apeiron Investment Group Ltd over six months ago via Macroaxis 
Purchase by Apeiron Investment Group Ltd of 68688 shares of Atai Life
Apeiron Investment Group Ltd over six months ago via Macroaxis 
Purchase by Apeiron Investment Group Ltd of 21900 shares of Atai Life
Apeiron Investment Group Ltd over six months ago via Macroaxis 
Purchase by Apeiron Investment Group Ltd of 19803 shares of Atai Life
Apeiron Investment Group Ltd over six months ago via Macroaxis 
Purchase by Apeiron Investment Group Ltd of 8961 shares of Atai Life
Apeiron Investment Group Ltd over six months ago via Macroaxis 
Purchase by Apeiron Investment Group Ltd of 65315 shares of Atai Life
Apeiron Investment Group Ltd over six months ago via Macroaxis 
Purchase by Apeiron Investment Group Ltd of 4967 shares of Atai Life
Apeiron Investment Group Ltd over six months ago via Macroaxis 
Purchase by Apeiron Investment Group Ltd of 55197 shares of Atai Life

Atai Life Sciences Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Atai Life Sciences Price Series Summation is a cross summation of Atai Life price series and its benchmark/peer.
.

Atai Life Notable Stakeholders

An Atai Life stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Atai Life often face trade-offs trying to please all of them. Atai Life's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Atai Life's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
ChengYaw Sun - CEO, DirectorProfile
Xiaofeng Ma - Co-Founder, Chairman, CEO and Chairman of Nominations CommitteeProfile
Jack Huang - President DirectorProfile
Jun Zhang - President DirectorProfile
Jianmin Ding - Sr. VP of Marketing and Bus. Devel.Profile
Yiu Tsui - Independent DirectorProfile
Andrew Yan - Independent DirectorProfile
Lin Wang - Co-Founder, Consultant and DirectorProfile
Hope Ni - Independent DirectorProfile
Alex Tong - VP of Bus. Devel. and Investor RelationsProfile
Amy Tung - VPProfile
Shuqiu Zhao - VPProfile
Benson Tsang - Independent ConsultantProfile

About Atai Life Management Performance

The success or failure of an entity such as Atai Life Sciences often depends on how effective the management is. Atai Life management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Atai Life management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Atai Life management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany. Atai Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people.
The data published in Atai Life's official financial statements usually reflect Atai Life's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Atai Life Sciences. For example, before you start analyzing numbers published by Atai Life accountants, it's critical to develop an understanding of what Atai Life's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Atai Life's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Atai Life's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Atai Life's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Atai Life Sciences. Please utilize our Beneish M Score to check the likelihood of Atai Life's management to manipulate its earnings.

Atai Life Workforce Analysis

Traditionally, organizations such as Atai Life use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Atai Life within its industry.

Atai Life Manpower Efficiency

Return on Atai Life Manpower

Revenue Per Employee7.7 K
Revenue Per Executive51.2 K
Net Loss Per Employee2.2 M
Net Loss Per Executive14.9 M
Working Capital Per Employee2.8 M
Working Capital Per Executive18.9 M
Please continue to Trending Equities. Note that the Atai Life Sciences information on this page should be used as a complementary analysis to other Atai Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for Atai Life Stock analysis

When running Atai Life Sciences price analysis, check to measure Atai Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atai Life is operating at the current time. Most of Atai Life's value examination focuses on studying past and present price action to predict the probability of Atai Life's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Atai Life's price. Additionally, you may evaluate how the addition of Atai Life to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Is Atai Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atai Life. If investors know Atai Life will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atai Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
(0.97) 
Market Capitalization
499.3 M
Quarterly Revenue Growth YOY
(0.91) 
Return On Assets
(0.22) 
Return On Equity
(0.54) 
The market value of Atai Life Sciences is measured differently than its book value, which is the value of Atai Life that is recorded on the company's balance sheet. Investors also form their own opinion of Atai Life's value that differs from its market value or its book value, called intrinsic value, which is Atai Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atai Life's market value can be influenced by many factors that don't directly affect Atai Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atai Life's value and its price as these two are different measures arrived at by different means. Investors typically determine Atai Life value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atai Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.